Generic Luvox® CR Launches

Released: 03/19/2013 By: Mike Partridge, RPh

On March 13, Par Pharmaceuticals received final FDA approval and launched the generic equivalent of Jazz Pharma’s Luvox® CR (fluvoxamine extended release) capsules.

Luvox® CR is indicated for the treatment of obsessive compulsive disorder (OCD), as defined in the DSM-IV. The brand item had U.S. annual sales of approximately $30M.